Compare Stocks: RGNT, MLSS, QTI, and NSPR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MLSS Milestone Scientific	$0.41	$0.45	$0.22 ▼ $0.60	$36.94M	1.08	859,782 shs	98,321 shs
NSPR InspireMD	$0.77	$0.79	$0.63 ▼ $2.57	$35.68M	0.83	143,852 shs	19,862 shs
QTI QT Imaging	$2.61	$2.89	$2.00 ▼ $8.50	$35.94M	N/A	33,281 shs	51,844 shs
RGNT Regentis Biomaterials	$1.81	$2.03	$1.23 ▼ $15.50	$9.38M	N/A	31,114 shs	22,811 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MLSS Milestone Scientific	0.00%	-8.22%	-15.25%	+23.45%	-21.44%
NSPR InspireMD	0.00%	-2.85%	-14.71%	+7.16%	-68.68%
QTI QT Imaging	0.00%	-1.14%	-10.31%	-30.77%	+1.05%
RGNT Regentis Biomaterials	0.00%	-4.23%	-13.81%	-56.17%	+180,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MLSS Milestone Scientific	$0.41	$0.45	$0.22 ▼ $0.60	$36.94M	1.08	859,782 shs	98,321 shs
NSPR InspireMD	$0.77	$0.79	$0.63 ▼ $2.57	$35.68M	0.83	143,852 shs	19,862 shs
QTI QT Imaging	$2.61	$2.89	$2.00 ▼ $8.50	$35.94M	N/A	33,281 shs	51,844 shs
RGNT Regentis Biomaterials	$1.81	$2.03	$1.23 ▼ $15.50	$9.38M	N/A	31,114 shs	22,811 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MLSS Milestone Scientific	0.00%	-8.22%	-15.25%	+23.45%	-21.44%
NSPR InspireMD	0.00%	-2.85%	-14.71%	+7.16%	-68.68%
QTI QT Imaging	0.00%	-1.14%	-10.31%	-30.77%	+1.05%
RGNT Regentis Biomaterials	0.00%	-4.23%	-13.81%	-56.17%	+180,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MLSS Milestone Scientific	3.00	Buy	$1.00	145.40% Upside
NSPR InspireMD	3.00	Buy	$4.50	486.40% Upside
QTI QT Imaging	2.00	Hold	N/A	N/A
RGNT Regentis Biomaterials	4.00	Strong Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest RGNT, MLSS, QTI, and NSPR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/17/2026	MLSS Milestone Scientific	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1.00
8/17/2026	MLSS Milestone Scientific	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Speculative Buy
7/10/2026	QTI QT Imaging	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MLSS Milestone Scientific	$9.42M	3.92	N/A	N/A	$0.11 per share	3.70
NSPR InspireMD	$10.84M	3.29	N/A	N/A	$1.83 per share	0.42
QTI QT Imaging	$18.92M	1.90	N/A	N/A	$0.54 per share	4.83
RGNT Regentis Biomaterials	N/A	N/A	N/A	N/A	$0.92 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MLSS Milestone Scientific	-$6.93M	-$0.04	N/A	N/A	N/A	-52.01%	-60.26%	-40.23%	N/A
NSPR InspireMD	-$19.92M	-$0.64	N/A	N/A	N/A	-413.96%	-69.42%	-57.68%	N/A
QTI QT Imaging	-$21.08M	-$1.57	N/A	20.08	N/A	-77.25%	-1,202.69%	-46.76%	11/9/2026 (Estimated)
RGNT Regentis Biomaterials	-$13.65M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest RGNT, MLSS, QTI, and NSPR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
9/11/2026	Q2 2026	RGNT Regentis Biomaterials	N/A	-$0.22	N/A	-$0.22	N/A	N/A
8/12/2026	Q2 2026	QTI QT Imaging	-$0.22	-$0.75	-$0.53	-$0.75	$7.60 million	$7.44 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A
NSPR InspireMD	N/A	N/A	N/A	N/A	N/A
QTI QT Imaging	N/A	N/A	N/A	N/A	N/A
RGNT Regentis Biomaterials	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MLSS Milestone Scientific	N/A	2.85	1.86
NSPR InspireMD	N/A	6.39	6.05
QTI QT Imaging	6.81	3.10	2.06
RGNT Regentis Biomaterials	N/A	5.62	2.65

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MLSS Milestone Scientific	5.79%
NSPR InspireMD	44.78%
QTI QT Imaging	24.19%
RGNT Regentis Biomaterials	N/A

Insider Ownership

Company	Insider Ownership
MLSS Milestone Scientific	9.22%
NSPR InspireMD	24.98%
QTI QT Imaging	25.40%
RGNT Regentis Biomaterials	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MLSS Milestone Scientific	15	90.64 million	58.61 million	Optionable
NSPR InspireMD	127	46.49 million	18.33 million	Optionable
QTI QT Imaging	32	13.77 million	10.27 million	N/A
RGNT Regentis Biomaterials	8	5.18 million	N/A	N/A

RGNT, MLSS, QTI, and NSPR Headlines

Recent News About These Companies

Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) Sees Significant Growth in Short Interest

September 19 at 3:22 AM | americanbankingnews.com

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.

September 18 at 10:15 AM | globenewswire.com

Regentis Biomaterials (NYSEAMERICAN:RGNT) Shares Down 0.6% - Should You Sell?

September 17, 2026 | americanbankingnews.com

Regentis Biomaterials (NYSE American: RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair

September 14, 2026 | markets.businessinsider.com

Regentis Biomaterials (RGNT) Advances GelrinC as a Potential New Approach to Knee Cartilage Repair

September 14, 2026 | finance.yahoo.com

Regentis Biomaterials Ltd: Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

September 11, 2026 | finanznachrichten.de

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

September 11, 2026 | accessnewswire.comA

Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC

August 28, 2026 | finance.yahoo.com

Regentis Biomaterials (RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

August 17, 2026 | finance.yahoo.com

Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

August 17, 2026 | usatoday.com

Regentis Biomaterials (RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

August 16, 2026 | finance.yahoo.com

Regentis Biomaterials (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

August 14, 2026 | markets.businessinsider.com

Regentis Biomaterials (RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair

August 4, 2026 | finance.yahoo.com

Regentis Biomaterials (NYSE American: RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair

August 3, 2026 | markets.businessinsider.com

Regentis Biomaterials (RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C

July 30, 2026 | finance.yahoo.com

Regentis Biomaterials (NYSE American: RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C

July 30, 2026 | markets.businessinsider.com

Regentis Biomaterials (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Milestones

July 29, 2026 | markets.businessinsider.com

Regentis Biomaterials (RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market

July 27, 2026 | finance.yahoo.com

Regentis Biomaterials (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market

July 27, 2026 | markets.businessinsider.com

Regentis Biomaterials Ltd: Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing ...

July 20, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

RGNT, MLSS, QTI, and NSPR Company Descriptions

Milestone Scientific NYSE:MLSS

$0.41 0.00 (0.00%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.40 -0.01 (-1.35%)

As of 07:55 AM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

InspireMD NYSE:NSPR

$0.77 0.00 (0.00%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.80 +0.03 (+3.60%)

As of 08:02 AM Eastern

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

QT Imaging NASDAQ:QTI

$2.61 0.00 (0.00%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$2.53 -0.08 (-3.03%)

As of 09/18/2026 07:30 PM Eastern

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

Regentis Biomaterials NYSEAMERICAN:RGNT

$1.81 0.00 (0.00%)

Closing price 09/18/2026 04:10 PM Eastern

Extended Trading

$1.82 +0.01 (+0.55%)

As of 08:24 AM Eastern

Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing tissue repair solutions which seek to restore the health. Regentis Biomaterials Ltd. is based in Herzliya, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RGNT, MLSS, QTI, and NSPR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RGNT, MLSS, QTI, and NSPR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RGNT, MLSS, QTI, and NSPR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RGNT, MLSS, QTI, and NSPR Company Descriptions

Milestone Scientific NYSE:MLSS

InspireMD NYSE:NSPR

QT Imaging NASDAQ:QTI

Regentis Biomaterials NYSEAMERICAN:RGNT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RGNT, MLSS, QTI, and NSPR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RGNT, MLSS, QTI, and NSPR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RGNT, MLSS, QTI, and NSPR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RGNT, MLSS, QTI, and NSPR Company Descriptions

Milestone Scientific NYSE:MLSS

InspireMD NYSE:NSPR

QT Imaging NASDAQ:QTI

Regentis Biomaterials NYSEAMERICAN:RGNT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools